ejemph Open Access Journal

European Journal of Emerging Medicine and Public Health

eISSN: Applied
Publication Frequency : 2 Issues per year.

  • Peer Reviewed & International Journal
Table of Content
Issues (Year-wise)
Loading…

Open Access iconOpen Access

ARTICLE

Neonatal Neuroblastoma: A Monograph on Pathogenesis, Diagnosis, and Management

1 Department of Pediatric Oncology, All India Institute of Medical Sciences (AIIMS), New Delhi, India
2 Division of Pediatric Surgery, Great Ormond Street Hospital for Children, London, United Kingdom
3 Department of Neonatology, National University Hospital, Singapore

Citations: Loading…
ABSTRACT VIEWS: 25   |   FILE VIEWS: 21   |   PDF: 21   HTML: 0   OTHER: 0   |   TOTAL: 46
Views + Downloads (Last 90 days)
Cumulative % included

Abstract

Neuroblastoma presenting in the neonatal period is a clinically and biologically heterogeneous entity with a wide spectrum of behaviors, from spontaneous regression to aggressive progression. This review synthesizes the current understanding of the disease to provide a clear framework for diagnosis and management. Based on a comprehensive review of foundational and recent literature, this article covers the key domains of epidemiology, pathogenesis, clinical presentation, and prognosis. Neonatal neuroblastoma accounts for approximately 5% of all cases and is driven by molecular features like MYCN amplification. Clinical presentations are highly variable, ranging from asymptomatic masses to life-threatening emergencies. Diagnosis relies on urinary catecholamines, multi-modal imaging, and histopathology, with the International Neuroblastoma Risk Group (INRG) system being critical for classification. The management has evolved to a successful risk-stratified approach where active observation is standard for low-risk disease, while surgery and chemotherapy are reserved for higher-risk patients. This strategy allows for therapy de-escalation in the majority of infants, leading to excellent survival in low- and intermediate-risk groups, though the prognosis for high-risk disease remains poor.


Keywords

Neonatal Neuroblastoma, Congenital Neuroblastoma, Spontaneous Regression, Pediatric Oncology

References

1. Alikärri S, Raitio A, Losty PD. Pre and postoperative diarrhoea associated with neuroblastoma resection – A systematic review of published studies. Eur J Surg Oncol. 2023;49(10):106921.

2. Matthay KK, et al. Neuroblastoma. Nat Rev Dis Primers. 2016;2:16078.

3. Maris JM, et al. Neuroblastoma. Lancet. 2007;369(9579):2106–2120.

4. Gutierrez JC, et al. Markedly improving survival of neuroblastoma: a 30-year analysis of 1,646 patients. Pediatr Surg Int. 2007;23(7):637–646.

5. Gigliotti AR, et al. Neuroblastoma in the newborn. A study of the Italian Neuroblastoma Registry. Eur J Cancer. 2009;45(18):3220–3227.


How to Cite

Neonatal Neuroblastoma: A Monograph on Pathogenesis, Diagnosis, and Management. (2024). European Journal of Emerging Medicine and Public Health, 1(01), 34-39. https://parthenonfrontiers.com/index.php/ejemph/article/view/176

Share Link